Stock Analiz

Ironwood Pharmaceuticals Inc. (IRWD) stock forecast and price target

Price $4.83 · data as of November 13, 2026

12-month price target

Average target$6.17
Upside / downside+27.8%
Analysts4
ConsensusBuy
Low $3.70Average $6.17High $10.00

Gold marker: average target · white marker: today’s price ($4.83)

Analyst ratings

Strong buy 1Buy 1Hold 2Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$1.30+420.0%$494M
Next fiscal year
ends December 31, 2027
$1.57+20.5%$504M
Next quarter
ends December 31, 2026
$0.39+4000.0%$136M
Quarter after
ends March 31, 2027
$0.30+27.1%$109M

Consensus of the analysts covering Ironwood Pharmaceuticals, updated daily. In the last 30 days 1 estimates were raised and 0 lowered.

Our model vs. Wall Street

Analysts see 27.8% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Ironwood Pharmaceuticals’s intrinsic value about 184% above today’s market value, and it scores 2.2 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Ironwood Pharmaceuticals stock price target?

The average 12-month target from 4 analysts is $6.17, 27.8% above the current price of $4.83 Targets range from $3.70 to $10.00.

Is Ironwood Pharmaceuticals a buy according to analysts?

The consensus rating is “Buy” (1 strong buy, 1 buy, 2 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Ironwood Pharmaceuticals expected to earn?

Analysts expect EPS of $1.30 for the fiscal year ending December 31, 2026 and $1.57 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.